Novartis launches takeover bid for MorphoSys
Novartis said it has launched a public offer to acquire MorphoSys, a German developer of cancer treatments, for a total of 2.7 billion euros.
POPULAR POSTS
At least five missing in landslide in central Kenya
May 16, 2024
The summer of 2023 was the hottest in 2,000 years
May 16, 2024
LIVE STREAM